Orgenesis Inc. (NASDAQ:ORGS – Get Free Report)’s share price shot up 3.1% during trading on Thursday . The stock traded as high as $2.60 and last traded at $2.58. 797 shares were traded during trading, a decline of 94% from the average session volume of 12,685 shares. The stock had previously closed at $2.50.
Orgenesis Stock Down 2.3 %
The business has a 50 day simple moving average of $2.52.
About Orgenesis
Orgenesis Inc, a biotech company, focuses on cell and gene therapies worldwide. It operates through two segments, Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare network consisting of research institutes and hospitals.
Further Reading
- Five stocks we like better than Orgenesis
- What is the Dogs of the Dow Strategy? Overview and Examples
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- Earnings Per Share Calculator: How to Calculate EPS
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- How to invest in marijuana stocks in 7 steps
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Receive News & Ratings for Orgenesis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orgenesis and related companies with MarketBeat.com's FREE daily email newsletter.
